Navigation Links
Michael J. Fox Foundation Awards $2.1 Million to Improve Drug Delivery in Parkinson's Disease
Date:3/27/2009

NEW YORK, March 27 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation announced that it has awarded approximately $2.1 million total to seven research teams working to improve drug delivery for Parkinson's disease.

The funding was awarded under the Foundation's Improving Delivery of Parkinson's Disease Therapeutics to the Brain. The program is designed to address two major challenges to the development of transformative treatments for Parkinson's disease: the need for non-invasive drug delivery technologies allowing therapeutics to cross the blood-brain barrier, and the need to more precisely understand how molecules move inside the central nervous system in order to target treatments to specific regions of the brain.

Funded projects are listed below. Full information on funded projects, including grant abstracts and researcher bios, is available on the Foundation's Searchable Database of Funded Grants.

Image-guided Gene Delivery for Parkinson's

Krysztof Bankiewicz, M.D., Ph.D., University of California, San Francisco

Convection Enhanced Delivery to Study the Pathophysiology Underlying the Clinical Features of Human Parkinson's Disease

Jeff Elias, M.D., University of Virginia, and Russell Lonser, M.D., National Institute of Neurodegenerative Disease and Stroke

Real-time Monitoring of Targeting, Delivery, and Spread of Therapeutic Agents in the Brain

Samir Jafri, Ph.D., University of Maryland, Baltimore, and Cha-Min Tang, M.D., Ph.D., University of Maryland School of Medicine

Utilizing Novel Tracers to Determine the Distribution of Therapeutic Agents In Vivo

RamakrishnaVenugopalan, Ph.D., Codman and Shurtleff, Inc.

Deep Brain Imaging to Determine the Movement of Compounds Relevant to Parkinson's Disease

Mark Saltzman, Ph.D., and Michael Levene, Ph.D., Yale University

Novel Antibodies for the Delivery of Parkinson's Therapeutics

Eric Shusta, Ph.D., and Clive Svendson, Ph.D., University of Wisconsin, Madison

Intranasal Gene Therapy: Next Steps

Barbara Lee Waszczak, Ph.D., Northeastern University

About The Michael J. Fox Foundation

The Michael J. Fox Foundation is dedicated to ensuring the development of better treatments, and ultimately a cure, for Parkinson's disease through an aggressively funded research agenda. MJFF has funded over $142 million in research to date.


'/>"/>
SOURCE Michael J. Fox Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Michael J. Fox Foundation Awards Up to $3 Million to Industry Teams to Jumpstart Promising PD Drug Development
2. Michael J. Fox Foundation Commits Up to $3 Million for Clinical Trials That Can Improve Treatment of Parkinsons Disease
3. New Michael J. Fox Foundation Initiative Will Drive Development of Web-Based Tools to Increase Patient Participation in Parkinsons Clinical Trials
4. Michael J. Fox Foundation Commits up to $10 Million for Pre-Clinical Drug Development Under Therapeutics Development Initiative
5. Michael J. Fox Foundation Announces $5.6-Million Award for Phase 2 Clinical Trial Studying Neuroprotective Potential of Inosine
6. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards
7. Michael J. Fox Foundation Awards $2.4 Million for Validation of Nine Promising Therapeutic Targets for Parkinsons Disease
8. Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinsons Therapeutics
9. Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee
10. Michael J. Fox Foundation Funds $1.1 Million for Cutting-Edge Approaches to Parkinsons Disease Under Rapid Response Innovation Awards 2008
11. Michael J. Fox Foundation Awards $2 Million for Research on Cognitive and Mood Symptoms of Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 If ... Leaders Scholarship is any indication, the future is in ... at www.diabetesscholars.org by the Diabetes Scholars Foundation ... the way of academic and community service excellence. ... since 2012, and continues to advocate for people with ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
(Date:6/24/2016)... ... , ... Marcy was in a crisis. Her son James, eight, was out of control. Prone ... physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If ... at my other children and say he was going to kill them. If we ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
Breaking Medicine News(10 mins):